The Indian Pharmaceutical Alliance (IPA) has announced its fifth edition of this year’s India Pharmaceutical Forum. Designed around the theme Patient Centricity and Integrated Quality Management, the forum will be held in Mumbai from February 27-28.
Reports suggest, Dr P D Vaghela, Secretary, Department of Pharmaceuticals, Government of India will allegedly deliver the keynote address and highlight the IPA guidelines on Market Complaints.
“We are in the midst of a patient-centred care revolution in healthcare. The 5th India Pharmaceutical Forum provides an apt opportunity for industry, regulators and other players to engage in discussions on patient centricity and quality management systems. At the same time, the forum will provide a platform to pharma and healthcare professionals to reflect on the journey so far in terms of Quality,” announced Sudarshan Jain, Secretary-General, IPA.
“India is the pharmacy of the world and accounts of approximately 20 per cent of market share globally in volume terms and IPA is committed to providing quality medicines to its consumers across the globe. For us patient safety and health is paramount,” he added further.
Quality, Capability Building, Affordability and Patient-Centric Approach are some of the ten sessions dedicated to the fifth India Pharmaceutical Forum.
The event will also see participation from CEOs of top Indian Pharma companies such as Lupin, Dr. Reddy’s, Sun Pharma, Cadila and Cipla among others.
